The latest update of “Global Anti-Obesity Prescription Drugs Market” released by Stratagem Market Insights, forecasts further growth in the global supply and demand. The market report builds upon our previous iteration and the new release reinforces the sentiment that the 2021-2028 period is expected to be a promising period for the global Anti-Obesity Prescription Drugs Market.
Overview of the Anti-Obesity Prescription Drugs Market:
Anti-obesity medication or drugs are pharmacological agents used to reduce or control weight. These medications modify one of the fundamental processes of the human body by altering either appetite or absorption of calories. Moreover, it reduces intestinal fat absorption by inhibiting pancreatic lipase. The global anti-obesity prescription drugs market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global anti-obesity prescription drugs market is expected to witness significant growth during the forecast period, owing to the growing adoption of a sedentary lifestyle worldwide.
Market Drivers
The growing prevalence of obesity worldwide is expected to drive the growth of the global anti-obesity prescription drugs market during the forecast period. According to the World Health Organization (WHO), in 2016, over 1.9 billion adults aged 18 years and above were overweight, of which around 650 million adults were obese. The alarming rise in the prevalence of obesity has led to increased demand for anti-obesity prescription drugs significantly in both developed and emerging economies. Thus, these factors are expected to drive the growth of the global anti-obesity prescription drugs market during the forecast period. Furthermore, increasing adoption of a sedentary lifestyle and rising geriatric population is expected to propel the global anti-obesity prescription drugs market growth over the forecast period.
Market Restraint
Side-effects associated with drugs are expected to hamper the global anti-obesity prescription drugs market growth over the forecast period.
Regional Insights
Among regions, North America is expected to witness robust growth in the global anti-obesity prescription drugs market during the forecast period. This is owing to high awareness regarding obesity among the population across the region. Furthermore, Asia Pacific is expected to register a significant growth rate over the forecast period, owing to increased expenditure on healthcare and the presence of robust reimbursement policies in the region.
Competitive Section
Key players operating in the global anti-obesity prescription drugs market are Boehringer Ingelheim GmbH, Merck & Co. Inc., Arena Pharmaceuticals Inc., Pfizer Inc., Takeda Pharmaceuticals Company Limited, GlaxoSmithKline plc, and F. Hoffmann-La Roche AG.
Market Estimation:
The data processed and validated in secondary and primary research is analyzed to compute market estimation statistics. It involves market breakdown, bottom-up, and top-down research. Our research team considers macroeconomic factors to forecast a comprehensive statistical time series. Each data point is validated through the process data triangulation method to derive the final market estimation.
COVID-19 Impact:
The updated report, free extract available, comes with an option to access premium features that covers extensive past, current, and future data. Other valuable updates to the global Anti-Obesity Prescription Drugs Market report include a reviewed and refined pricing model for manufacturing and launch prices. The report incorporates new content to help give decision-makers key knowledge about the market and offers up-to-date forecasts accounting for the economic situation and impact of COVID-19.
Market Competition Assessment:
The Anti-Obesity Prescription Drugs Market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are
- 7TM Pharma
- Zydus Cadila
- Akrimax Pharmaceuticals
- Zealand Pharma
- Arrowhead Research
- Arena Pharmaceuticals Inc.
- Compellis Pharmaceuticals
- Yungjin Pharm
- Alpex Pharma SA
- Bridge BioResearch
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2028. For the purpose of this study, Stratagem Market Insights has segmented the global Anti-Obesity Prescription Drugs Market report on the basis of Types, Applications, and Regions.
By Product Type, the market is primarily segmented into:
- Prescription Drugs
- OTC Drugs
By Applications, the market is segmented into:
- Hospital
- Clinics
- Pharmacies
The report covers the following Regions:
- North America
- Latin America
- Europe
- Asia Pacific
- Africa
- Middle East
Primary Research Insights:
The process of primary research starts with the verification and validation of every detail obtained in secondary research. This is done with the help of industry experts and in-house analysts who check the authentication of the data. Stratagem Market Insights also ensures that our research is not restricted by certain boundaries, which is why we consult each individual in the value chain including raw materials suppliers, local vendors, wholesale dealers, distributors, etc. We also make sure that every detail provided in the document will hold a certain value and it will not be trivial information. Moreover, current market trends, growth opportunities, drivers, and restraints are computed in primary research only.
The Report Sheds Light on Various Aspects of the Market, Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- Which regions might see the demand maturing in certain segments in near future?
- Which government regulations might challenge the status of key regional markets?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Why You Should Buy This Report:
- The report provides an all-inclusive environment of the analysis for the market
- In-depth secondary research and primary interviews
- Impact of various social, political, and economic factors
- Porter’s Five Forces Analysis
- Competitive Landscape
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-Obesity Prescription Drugs Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Anti-Obesity Prescription Drugs Market Share by Application: 2021 VS 2027
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Anti-Obesity Prescription Drugs Market
1.6.1 How the Covid-19 is Affecting the Anti-Obesity Prescription Drugs Market
1.6.1.1 Anti-Obesity Prescription Drugs Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Anti-Obesity Prescription Drugs Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Anti-Obesity Prescription Drugs Market Perspective (2015-2027)
2.2 Anti-Obesity Prescription Drugs Market Growth Trends by Regions
2.2.1 Anti-Obesity Prescription Drugs Market Size by Regions: 2015 VS 2021 VS 2027
2.2.2 Anti-Obesity Prescription Drugs Market Historic Market Share by Regions (2015-2021)
2.2.3 Anti-Obesity Prescription Drugs Market Forecasted Market Size by Regions (2021-2027)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Anti-Obesity Prescription Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Anti-Obesity Prescription Drugs Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Anti-Obesity Prescription Drugs Market Players by Market Size
3.1.1 Global Top Anti-Obesity Prescription Drugs Market Players by Revenue (2015-2021)
3.1.2 Global Anti-Obesity Prescription Drugs Market Revenue Market Share by Players (2015-2021)
3.1.3 Global Anti-Obesity Prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anti-Obesity Prescription Drugs Market Concentration Ratio
3.2.1 Global Anti-Obesity Prescription Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Anti-Obesity Prescription Drugs Market Revenue in 2019
3.3 Anti-Obesity Prescription Drugs Market Key Players Head office and Area Served
3.4 Key Players Anti-Obesity Prescription Drugs Market Product Solution and Service
3.5 Date of entering into Anti-Obesity Prescription Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2027)
4.1 Global Anti-Obesity Prescription Drugs Market Historic Market Size by Type (2015-2021)
4.2 Global Anti-Obesity Prescription Drugs Market Forecasted Market Size by Type (2021-2027)
5 Anti-Obesity Prescription Drugs Market Breakdown Data by Application (2015-2027)
5.1 Global Anti-Obesity Prescription Drugs Market Size by Application (2015-2021)
5.2 Global Anti-Obesity Prescription Drugs Market Forecasted Market Size by Application (2021-2027)
6 North America
6.1 North America Anti-Obesity Prescription Drugs Market Size (2015-2021)
6.2 Anti-Obesity Prescription Drugs Market Key Players in North America (2019-2021)
6.3 North America Anti-Obesity Prescription Drugs Market Size by Type (2015-2021)
6.4 North America Anti-Obesity Prescription Drugs Market Size by Application (2015-2021)
7 Europe
7.1 Europe Anti-Obesity Prescription Drugs Market Size (2015-2021)
7.2 Anti-Obesity Prescription Drugs Market Key Players in Europe (2019-2021)
7.3 Europe Anti-Obesity Prescription Drugs Market Size by Type (2015-2021)
7.4 Europe Anti-Obesity Prescription Drugs Market Size by Application (2015-2021)
8 China
8.1 China Anti-Obesity Prescription Drugs Market Size (2015-2021)
8.2 Anti-Obesity Prescription Drugs Market Key Players in China (2019-2021)
8.3 China Anti-Obesity Prescription Drugs Market Size by Type (2015-2021)
8.4 China Anti-Obesity Prescription Drugs Market Size by Application (2015-2021)
9 Japan
9.1 Japan Anti-Obesity Prescription Drugs Market Size (2015-2021)
9.2 Anti-Obesity Prescription Drugs Market Key Players in Japan (2019-2021)
9.3 Japan Anti-Obesity Prescription Drugs Market Size by Type (2015-2021)
9.4 Japan Anti-Obesity Prescription Drugs Market Size by Application (2015-2021)
10 Southeast Asia
10.1 Southeast Asia Anti-Obesity Prescription Drugs Market Size (2015-2021)
10.2 Anti-Obesity Prescription Drugs Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Anti-Obesity Prescription Drugs Market Size by Type (2015-2021)
10.4 Southeast Asia Anti-Obesity Prescription Drugs Market Size by Application (2015-2021)
11 India
11.1 India Anti-Obesity Prescription Drugs Market Size (2015-2021)
11.2 Anti-Obesity Prescription Drugs Market Key Players in India (2019-2021)
11.3 India Anti-Obesity Prescription Drugs Market Size by Type (2015-2021)
11.4 India Anti-Obesity Prescription Drugs Market Size by Application (2015-2021)
12 Central & South America
12.1 Central & South America Anti-Obesity Prescription Drugs Market Size (2015-2021)
12.2 Anti-Obesity Prescription Drugs Market Key Players in Central & South America (2019-2021)
12.3 Central & South America Anti-Obesity Prescription Drugs Market Size by Type (2015-2021)
12.4 Central & South America Anti-Obesity Prescription Drugs Market Size by Application (2015-2021)
13 Key Players Profiles
13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Anti-Obesity Prescription Drugs Market Introduction
13.4 Anti-Obesity Prescription Drugs Market Business (2015-2021)
13.5 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
Table 1. Anti-Obesity Prescription Drugs Market Key Market Segments
Table 2. Key Players Covered: Ranking by Anti-Obesity Prescription Drugs Market Revenue
Table 3. Ranking of Global Top Anti-Obesity Prescription Drugs Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anti-Obesity Prescription Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Anti-Obesity Prescription Drugs Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Anti-Obesity Prescription Drugs Market Players to Combat Covid-19 Impact
Table 10. Global Anti-Obesity Prescription Drugs Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 11. Global Anti-Obesity Prescription Drugs Market Size by Regions (US$ Million): 2021 VS 2027
Table 12. Global Anti-Obesity Prescription Drugs Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global Anti-Obesity Prescription Drugs Market Share by Regions (2015-2021)
Table 14. Global Anti-Obesity Prescription Drugs Market Forecasted Market Size by Regions (2021-2027) (US$ Million)
Table 15. Global Anti-Obesity Prescription Drugs Market Share by Regions (2021-2027)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Anti-Obesity Prescription Drugs Market Growth Strategy
Table 20. Main Points Interviewed from Key Anti-Obesity Prescription Drugs Market Players
Table 21. Global Anti-Obesity Prescription Drugs Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global Anti-Obesity Prescription Drugs Market Share by Players (2015-2021)
Table 23. Global Top Anti-Obesity Prescription Drugs Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Obesity Prescription Drugs Market as of 2019)
Table 24. Global Anti-Obesity Prescription Drugs Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Anti-Obesity Prescription Drugs Market Product Solution and Service
Table 27. Date of entering into Anti-Obesity Prescription Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Anti-Obesity Prescription Drugs Market Size by Type (2015-2021) (Million US$)
Table 30. Global Anti-Obesity Prescription Drugs Market Size Share by Type (2015-2021)
Table 31. Global Anti-Obesity Prescription Drugs Market Revenue Market Share by Type (2021-2027)
Table 31. Global Anti-Obesity Prescription Drugs Market Size Share by Application (2015-2021)
Table 33. Global Anti-Obesity Prescription Drugs Market Size by Application (2015-2021) (Million US$)
Table 34. Global Anti-Obesity Prescription Drugs Market Size Share by Application (2021-2027)
Table 35. North America Key Players Anti-Obesity Prescription Drugs Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Anti-Obesity Prescription Drugs Market Share (2019-2021)
Table 37. North America Anti-Obesity Prescription Drugs Market Size by Type (2015-2021) (Million US$)
Table 38. North America Anti-Obesity Prescription Drugs Market Share by Type (2015-2021)
Table 39. North America Anti-Obesity Prescription Drugs Market Size by Application (2015-2021) (Million US$)
Table 40. North America Anti-Obesity Prescription Drugs Market Share by Application (2015-2021)
Table 41. Europe Key Players Anti-Obesity Prescription Drugs Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Anti-Obesity Prescription Drugs Market Share (2019-2021)
Table 43. Europe Anti-Obesity Prescription Drugs Market Size by Type (2015-2021) (Million US$)
Table 44. Europe Anti-Obesity Prescription Drugs Market Share by Type (2015-2021)
Table 45. Europe Anti-Obesity Prescription Drugs Market Size by Application (2015-2021) (Million US$)
Table 46. Europe Anti-Obesity Prescription Drugs Market Share by Application (2015-2021)
Table 47. China Key Players Anti-Obesity Prescription Drugs Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players Anti-Obesity Prescription Drugs Market Share (2019-2021)
Table 49. China Anti-Obesity Prescription Drugs Market Size by Type (2015-2021) (Million US$)
Table 50. China Anti-Obesity Prescription Drugs Market Share by Type (2015-2021)
Table 51. China Anti-Obesity Prescription Drugs Market Size by Application (2015-2021) (Million US$)
Table 52. China Anti-Obesity Prescription Drugs Market Share by Application (2015-2021)
Table 53. Japan Key Players Anti-Obesity Prescription Drugs Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Anti-Obesity Prescription Drugs Market Share (2019-2021)
Table 55. Japan Anti-Obesity Prescription Drugs Market Size by Type (2015-2021) (Million US$)
Table 56. Japan Anti-Obesity Prescription Drugs Market Share by Type (2015-2021)
Table 57. Japan Anti-Obesity Prescription Drugs Market Size by Application (2015-2021) (Million US$)
Table 58. Japan Anti-Obesity Prescription Drugs Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Anti-Obesity Prescription Drugs Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Anti-Obesity Prescription Drugs Market Share (2019-2021)
Table 61. Southeast Asia Anti-Obesity Prescription Drugs Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Anti-Obesity Prescription Drugs Market Share by Type (2015-2021)
Table 63. Southeast Asia Anti-Obesity Prescription Drugs Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Anti-Obesity Prescription Drugs Market Share by Application (2015-2021)
Table 65. India Key Players Anti-Obesity Prescription Drugs Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players Anti-Obesity Prescription Drugs Market Share (2019-2021)
Table 67. India Anti-Obesity Prescription Drugs Market Size by Type (2015-2021) (Million US$)
Table 68. India Anti-Obesity Prescription Drugs Market Share by Type (2015-2021)
Table 69. India Anti-Obesity Prescription Drugs Market Size by Application (2015-2021) (Million US$)
Table 70. India Anti-Obesity Prescription Drugs Market Share by Application (2015-2021)
Table 71. Central & South America Key Players Anti-Obesity Prescription Drugs Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Anti-Obesity Prescription Drugs Market Share (2019-2021)
Table 73. Central & South America Anti-Obesity Prescription Drugs Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Anti-Obesity Prescription Drugs Market Share by Type (2015-2021)
Table 75. Central & South America Anti-Obesity Prescription Drugs Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Anti-Obesity Prescription Drugs Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Anti-Obesity Prescription Drugs Market Business (2015-2021) (Million US$)
Table 81. Recent Development
List of Figures
Figure 1. Global Anti-Obesity Prescription Drugs Market Share by Type: 2021 VS 2027
Figure 2. Global Anti-Obesity Prescription Drugs Market Share by Application: 2021 VS 2027
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Anti-Obesity Prescription Drugs Market Report Years Considered
Figure 8. Global Anti-Obesity Prescription Drugs Market Size YoY Growth 2015-2027 (US$ Million)
Figure 9. Global Anti-Obesity Prescription Drugs Market Share by Regions: 2021 VS 2027
Figure 10. Global Anti-Obesity Prescription Drugs Market Share by Regions (2021-2027)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Anti-Obesity Prescription Drugs Market Share by Players in 2019
Figure 13. Global Top Anti-Obesity Prescription Drugs Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Anti-Obesity Prescription Drugs Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Anti-Obesity Prescription Drugs Market Revenue in 2019
Figure 15. North America Anti-Obesity Prescription Drugs Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Anti-Obesity Prescription Drugs Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Anti-Obesity Prescription Drugs Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Anti-Obesity Prescription Drugs Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Anti-Obesity Prescription Drugs Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Anti-Obesity Prescription Drugs Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Anti-Obesity Prescription Drugs Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
Request Discount 
Inquire Before Buy
